Nasus Pharma, Ltd. (NSRX) Forward Price-to-Revenue Multiple

Corporate emblem and logo of Nasus Pharma Ltd (NSRX)

Stringent FDA requirements and testing costs create significant barriers to entry for competitors. The forward price-to-sales valuation in the daily price action on the GURU.Markets chart demonstrates the expectation vector, where 0.00 captures the magnitude of this parameter. Nasus Pharma Ltd (NSRX) relies on scientific alliances to develop nasal powders for business growth, while streamlined distribution through pharmacy chains ensures therapy accessibility.

NSRX Nasus Pharma, Ltd.: Market Cap to Expected Sales Ratio in the range 08/14/2025 - 08/16/2025

Financial and market metric breakdowns for Nasus Pharma (NSRX)

- market price and analyst price targets:
Summary company analysis:Nasus Pharma Ltd NSRX
Original product of nasuspharma.com

To filter for quality assets, investors utilize the forward P/S ratio, which compares the market value of a business with projected sales volume to assess growth potential. In the case of Nasus Pharma Ltd (NSRX), this metric measures the scaling efficiency of nasal technologies, where low production costs during mass distribution should expand margins, reflecting the trajectory of the forward P/S.